[Effects of bimolane on size, metastases and cyclic AMP levels of Lewis lung carcinoma].
Kong-wei Huang, Nai-wu Fu, Yufeng Ren
Abstract
Kong-wei Huang, Nai-wu Fu, Yufeng Ren
Abstract
Bimolane (AT1727), 1,2-bis (4-morphplinomethy1-3,5-dioxopiperazinyl)-ethane, is a derivative of ICRF154. It was first synthesized by Shanghai Institute of Materia Medica, Chinese Academy of Sciences. It slightly inhibited tumor growth and markedly inhibited the spontaneous pulmonary metastases of Lewis lung carcinoma in C57BL/6 mice. Adenosine cyclic-3’, 5’-monophosphate (cAMP) was assayed by Camp-dependent protein kinase binding assay in tumor tissue and plasma. Bimolane elevated moderately the Camp levels in primary tumor tissue of Lewis lung carcinoma. The cAMP level of plasma in normal C57BL/6 mice was not significantly different from that in C57BL/6 mice bearing Lewis lung carcinoma. Bimolane did not change the cAMP levels of plasma in C57BL/6 mice bearing Lewis ling carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Bimolane (AT1727), 1,2-bis (4-morphplinomethy1-3,5-dioxopiperazinyl)-ethane, is a derivative of ICRF154. It was first synthesized by Shanghai Institute of Materia Medica, Chinese Academy of Sciences. It slightly inhibited tumor growth and markedly inhibited the spontaneous pulmonary metastases of Lewis lung carcinoma in C57BL/6 mice. Adenosine cyclic-3’, 5’-monophosphate (cAMP) was assayed by Camp-dependent protein kinase binding assay in tumor tissue and plasma. Bimolane elevated moderately the Camp levels in primary tumor tissue of Lewis lung carcinoma. The cAMP level of plasma in normal C57BL/6 mice was not significantly different from that in C57BL/6 mice bearing Lewis lung carcinoma. Bimolane did not change the cAMP levels of plasma in C57BL/6 mice bearing Lewis ling carcinoma.
Key concepts: Lewis lung carcinoma, Carcinoma, Lung, Cyclic adenosine monophosphate, Internal medicine, Endocrinology, Adenosine, Protein kinase A